IP Library › Granted Patent US 12,303,163
Granted Patent B2
US 12,303,163 · App. 18/094,534 · Granted May 20, 2025

Transperineal prostate biopsy device, systems, and methods of use

Inventor: Matthew J. Allaway (Cumberland, MD)
A61B17/3403A61B8/0841A61B8/12A61B10/0241A61B10/04A61B90/39A61B2010/045A61B2017/00274A61B2017/00477A61B2017/3405A61B2017/3411A61B2017/3413A61B2018/00547A61B18/02A61B18/12A61B2090/3925A61B2090/3933A61B2090/3954A61B2090/3966
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,163
App. No.
18/094,534
Granted
May 20, 2025
Kind
B2
Abstract

A method of performing a transperineal biopsy procedure including the steps of: inserting an access needle into one of a plurality of needle receiving ports of a displacement member of a transperineal biopsy guide that is secured to the transrectal ultrasound probe; securing the access needle to the displacement member such that a position of the access needle relative to the displacement member is maintained; imaging the prostate of the patient with the transrectal ultrasound probe; inserting the access needle into the perineal access site of the patient; and inserting the biopsy needle through the access needle and into the prostate of the patient.

Claims (41)

1. A method of performing a medical procedure on a prostate of a patient, the method comprising:

image the prostate with a transrectal medical imaging probe while a guide is supported on the transrectal medical imaging probe and a first tubular body is secured to the guide such that proximal movement of the first tubular body relative to the guide is restrained;

extend the first tubular body through a perforation point on a perineum of the patient into subcutaneous tissue of the perineum, a longitudinal axis of the first tubular body extending towards the prostate and into a focal range of the transrectal medical imaging probe; and

extend a medical device through a lumen of the first tubular body along the longitudinal axis to a first target location of the prostate located in the focal range and perform the medical procedure at the first target location.

2. The method of claim 1 , further comprising securing the guide to the transrectal medical imaging probe.

3. The method of claim 1 , wherein the first tubular body includes an access needle.

4. The method of claim 3 , wherein the access needle has a gauge of between 18 and 14, inclusive.

5. The method of claim 1 , wherein the transrectal medical imaging probe includes ultrasound and the focal range includes an ultrasound focal range.

6. The method of claim 1 , wherein the medical device delivers energy to the first target location as part of the medical procedure.

7. The method of claim 1 , wherein the medical procedure includes focal therapy of prostate cancer.

8. The method of claim 1 , wherein the medical device includes a cryoablation probe and the medical procedure includes treatment of prostate cancer via the cryoablation probe.

9. The method of claim 1 , wherein the medical device includes a radiofrequency instrument and the medical procedure includes treatment of prostate cancer via the radiofrequency instrument.

10. The method of claim 1 , wherein the medical device includes a thermotherapy instrument and the medical procedure includes treatment of prostate cancer via the thermotherapy instrument.

11. The method of claim 1 , wherein the medical device includes a second tubular body and a fluid is injected through a lumen of the second tubular body as part of the medical procedure.

12. The method of claim 11 , wherein the fluid includes a medicament.

13. The method of claim 12 , wherein the second tubular body is part of a syringe and the medicament includes an anesthetic.

14. The method of claim 1 , wherein the medical device includes a biopsy device and the medical procedure includes taking a biopsy of the prostate.

15. The method of claim 1 , further comprising, without withdrawing the first tubular body from the perforation point on the perineum, extend the medical device through the first tubular body along the longitudinal axis to a second target location of the prostate located in the focal range and perform the medical procedure at the second target location.

16. The method of claim 1 , wherein the perforation point on the perineum is at a midpoint between a lateral edge of the prostate and a urethra along an x axis, and a midpoint between an anterior capsule and a posterior capsule along a y axis.

17. The method of claim 1 , wherein the guide comprises a channel through which the first tubular body extends, the channel being configured so as to hold the first tubular body such that the longitudinal axis of the first tubular body extends towards the focal range of the transrectal medical imaging probe.

18. The method of claim 17 , wherein the guide further comprises a mount and a platform supported on the mount, the mount securing the guide to the transrectal medical imaging probe, the channel defined in the platform, the platform being displaceable relative to the mount such that the channel can be displaced along at least a portion of a length of the transrectal medical imaging probe.

19. The method of claim 18 , wherein the channel includes a hole extending through the platform.

20. The method of claim 18 , wherein the guide further comprises a stabilization structure between the platform and mount, the platform being slidable along the stabilization structure.

21. The method of claim 1 , wherein the medical procedure is performed with real-time visualization provided by the imaging of the prostate with the transrectal medical imaging probe.

22. The method of claim 1 , wherein the first tubular body is secured to the guide via a threaded arrangement.

23. The method of claim 1 , wherein the first tubular body is coupled to a hub at an end thereof, and wherein the first tubular body is secured to the guide such that rotation of the first tubular body is inhibited.

24. The method of claim 1 , wherein the first tubular body is coupled to a hub at an end thereof, and wherein the hub and a portion of the guide are in engagement with each other when the first tubular body is secured to the guide.

25. The method of claim 24 , wherein the portion of the guide is a platform of the guide, the platform including an opening through which the first tubular body extends, the platform further including a proximal-facing side and a recess aligned with the opening on the proximal facing-side, wherein at least a portion of the hub is received within the recess when the first tubular body is secured to the guide.

26. The method of claim 25 , wherein the recess and the hub include complementary surfaces that interface when the at least a portion of the hub is received in the recess such that rotation of the first tubular body within the opening is inhibited.

27. The method of claim 26 , wherein the hub includes at least one raised surface feature, and the recess includes at least one recessed feature configured to receive the at least one raised surface feature of the hub.

28. The method of claim 24 , wherein the portion of the guide is a platform of the guide, the platform configured to position the first tubular body at a plurality of heights relative to the transrectal medical imaging probe.

29. The method of claim 1 , wherein the guide includes a stabilization structure and a platform, the first tubular body being secured to the platform such that proximal movement of the first tubular body relative to the platform is restrained, and

the method further comprising moving the platform distally relative to the stabilization structure of the guide to secure the platform in a distal-most position.

30. The method of claim 29 , wherein, in the distal-most position, further distal movement of the platform relative to the stabilization structure is prevented and proximal movement of the platform relative to the stabilization structure is restrained.

31. The method of claim 29 , wherein moving the platform distally relative to the stabilization structure of the guide causes a portion of the platform to ride up and over a ramp feature of the stabilizing structure, wherein, when the portion of the platform has distally passed an apex of the ramp feature, the platform is held by the ramp feature in the distal-most position.

32. The method of claim 31 , wherein the ramp feature distally slopes upward until the apex, at which point the ramp distally slopes downward, the portion of the platform being distal the apex when the platform is held by the ramp feature in the distal-most position.

33. The method of claim 29 , wherein the stabilization structure comprises a pair of stabilization members.

34. The method of claim 29 , further comprising contacting the perineum with a distal surface of the stabilization structure of the guide.

35. The method of claim 34 , wherein the distal surface comprises a pair of distal surfaces, wherein the platform is configured to position the first tubular body between the pair of distal surfaces.

36. The method of claim 1 , wherein the guide includes a stabilization structure and a platform pivotally coupled to the stabilization structure, the first tubular body being secured to the platform such that proximal movement of the first tubular body relative to the platform is restrained.

37. The method of claim 36 , further comprising pivoting the platform relative to the stabilization structure, the platform pivoting about an axis transverse to the longitudinal axis of the first tubular body when the first tubular body is secured to the platform.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2026
From: CORBIN CLINICAL RESOURCES, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 075734/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2026
From: CORBIN CLINICAL RESOURCES, LLC
To: CORBIN CLINICAL RESOURCES, INC.
Reel/Frame 075833/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2023
From: ALLAWAY, MATTHEW J.
To: CORBIN CLINICAL RESOURCES, LLC
Reel/Frame 062312/0252 →
Continuity (10)
Continuation 17698641 · Mar 18, 2022
Continuation 17494962 · Oct 6, 2021
Continuation In Part 17314845 · May 7, 2021
Continuation 16115180 · Aug 28, 2018
Continuation 14677286 · Apr 2, 2015
Continuation In Part 16991150 · Aug 12, 2020
Continuation 14874104 · Oct 2, 2015
Continuation In Part 14677286 · Apr 2, 2015
Provisional Application 61974826 · Apr 3, 2014
Related Publication 20230157719A1 · May 25, 2023
References Cited (295)
US 4735215A · Goto et al. · 1988 [cited by applicant]
US 4742829A · Law et al. · 1988 [cited by applicant]
US 4776346A · Beraha et al. · 1988 [cited by applicant]
US 4838506A · Cooper · 1989 [cited by applicant]
US 4911173A · Terwilliger · 1990 [cited by applicant]
US 5047036A · Koutrouvelis · 1991 [cited by applicant]
US 5161542A · Palestrant · 1992 [cited by applicant]
US 5494039A · Onik · 1996 [cited by examiner]
US 5800389A · Burney et al. · 1998 [cited by applicant]
US 5871448A · Ellard · 1999 [cited by applicant]
US 5931786A · Whitmore, III et al. · 1999 [cited by applicant]
US 5976092A · Chinn · 1999 [cited by applicant]
US 6398711B1 · Green et al. · 2002 [cited by applicant]
US 6485426B2 · Sandhu · 2002 [cited by applicant]
US 6485469B1 · Stewart et al. · 2002 [cited by applicant]
US 7959573B2 · Furia · 2011 [cited by applicant]
US 8057432B2 · Flagle et al. · 2011 [cited by applicant]
US 8403842B2 · Sakhel · 2013 [cited by applicant]
US 10064681B2 · Allaway · 2018 [cited by applicant]
US 10743909B2 · Allaway · 2020 [cited by applicant]
US 10743910B2 · Allaway · 2020 [cited by applicant]
US 10743911B2 · Allaway · 2020 [cited by applicant]
US 11096762B2 · Allaway · 2021 [cited by applicant]
US 11246677B2 · Allaway · 2022 [cited by applicant]
US 11446056B2 · Allaway · 2022 [cited by applicant]
US 11547436B2 · Allaway · 2023 [cited by applicant]
US 20020061300A1 · Gokcen · 2002 [cited by applicant]
US 20020087152A1 · Mikus et al. · 2002 [cited by applicant]
US 20020123689A1 · Furia · 2002 [cited by applicant]
US 20020156361A1 · Popowski et al. · 2002 [cited by applicant]
US 20030153850A1 · Davis · 2003 [cited by examiner]
US 20030176759A1 · Hogendijk et al. · 2003 [cited by applicant]
US 20030212414A1 · Sonek · 2003 [cited by applicant]
US 20040031721A1 · Mann · 2004 [cited by applicant]
US 20040143188A1 · Barzell et al. · 2004 [cited by applicant]
US 20040162458A1 · Green · 2004 [cited by examiner]
US 20040167542A1 · Solar et al. · 2004 [cited by applicant]
US 20040220444A1 · Hogendijk et al. · 2004 [cited by applicant]
US 20050159676A1 · Taylor · 2005 [cited by examiner]
US 20050283120A1 · Wang · 2005 [cited by applicant]
US 20060241477A1 · Sasady et al. · 2006 [cited by applicant]
US 20070043291A1 · Fidel · 2007 [cited by examiner]
US 20070073219A1 · Yang · 2007 [cited by applicant]
US 20070233157A1 · Mark et al. · 2007 [cited by applicant]
US 20080004481A1 · Bax · 2008 [cited by examiner]
US 20080027007A1 · Benner et al. · 2008 [cited by applicant]
US 20080039889A1 · Lamson et al. · 2008 [cited by applicant]
US 20080154198A1 · Wei · 2008 [cited by applicant]
US 20080221453A1 · Suri et al. · 2008 [cited by applicant]
US 20090030339A1 · Cheng · 2009 [cited by examiner]
US 20090093715A1 · Downey et al. · 2009 [cited by applicant]
US 20090234369A1 · Bax et al. · 2009 [cited by applicant]
US 20090292224A1 · Bowman et al. · 2009 [cited by applicant]
US 20100036245A1 · Yu et al. · 2010 [cited by applicant]
US 20100049186A1 · Ingle et al. · 2010 [cited by applicant]
US 20100160711A1 · Noyes · 2010 [cited by applicant]
US 20100172559A1 · Kumar et al. · 2010 [cited by applicant]
US 20100204688A1 · Hoey et al. · 2010 [cited by applicant]
US 20110009748A1 · Greene et al. · 2011 [cited by applicant]
US 20110071380A1 · Goldenberg · 2011 [cited by examiner]
US 20110142936A1 · Campbell et al. · 2011 [cited by applicant]
US 20110319759A1 · Liu · 2011 [cited by examiner]
US 20120010512A1 · O'Laughlin et al. · 2012 [cited by applicant]
US 20120203095A1 · Krieger et al. · 2012 [cited by applicant]
US 20120245455A1 · Bauman · 2012 [cited by examiner]
US 20130142875A1 · Shemi · 2013 [cited by examiner]
US 20130310680A1 · Werahera et al. · 2013 [cited by applicant]
US 20140039314A1 · Stoianovici · 2014 [cited by examiner]
US 20140094774A1 · Blanchard · 2014 [cited by applicant]
US 20150119715A1 · Baumann · 2015 [cited by examiner]
US 20150282880A1 · Allaway · 2015 [cited by applicant]
US 20150366544A1 · Yap · 2015 [cited by examiner]
US 20160022309A1 · Allaway · 2016 [cited by applicant]
US 20160081736A1 · Hoey et al. · 2016 [cited by applicant]
US 20160242810A1 · Neice · 2016 [cited by applicant]
US 20160243232A1 · Pickett · 2016 [cited by applicant]
US 20180168711A1 · Hoey et al. · 2018 [cited by applicant]
US 20180193080A1 · Hoey et al. · 2018 [cited by applicant]
US 20180360557A1 · Allaway · 2018 [cited by applicant]
US 20190231386A1 · Allaway · 2019 [cited by applicant]
US 20190231387A1 · Allaway · 2019 [cited by applicant]
US 20200214768A1 · Baumann et al. · 2020 [cited by applicant]
US 20200367925A1 · Allaway · 2020 [cited by applicant]
US 20210259801A1 · Allaway · 2021 [cited by applicant]
US 20210338267A1 · Allaway · 2021 [cited by applicant]
US 20220022996A1 · Allaway · 2022 [cited by applicant]
US 20220168012A1 · Wen et al. · 2022 [cited by applicant]
US 20220202444A1 · Allaway · 2022 [cited by applicant]
JP 4550531B2 · 2010 [cited by applicant]
WO WO9934735A1 · 1999 [cited by applicant]
WO WO2006089426A1 · 2006 [cited by applicant]
WO WO2013155156A1 · 2013 [cited by applicant]
USPTO-PTAB, Decision Denying Institution of Post-Grant Review, [cited by applicant]
USPTO-PTAB, Patent Owner Preliminary Response to Post-Grant Review Petition, [cited by applicant]
USPTO-PTAB, Patent Owner Sur-Reply to Petitioner's Reply to Preliminary Response, [cited by applicant]
USPTO-PTAB, Petition for Post-Grant Review, [cited by applicant]
USPTO-PTAB, Petitioner's Reply to Patent Owner's Preliminary Response, [cited by applicant]
PGR Exhibit 1003, Declaration of Edward J. Yun, M.D., dated Jul. 19, 2023, 121 pgs. [cited by applicant]
PGR Exhibit 1006, Bard Biopsy Systems, Bard® TruGuide® Disposable Coaxial Biopsy Needle Instructions for Use, May 2012, 7 pgs. [cited by applicant]
PGR Exhibit 1013, Declaration of Ingrid Hsieh-Yee, PhD, dated Jul. 17, 2023, 309 pgs. [cited by applicant]
PGR Exhibit 1014, Declaration of Nico Eelbode, dated Jun. 11, 2023, 4 pgs. [cited by applicant]
PGR Exhibit 1018, The Parties Claim Construction Statements in [cited by applicant]
PGR Exhibit 1019, Patent Owner's Amended infringement Contentions for the '436 Patent in [cited by applicant]
Aba Yazid et al. Integrating Deflection Models and Image Feedback for Real-Time Flexible Needle Steering. IEEE Transactions on Robotics Apr. 2013; vol. 29, No. 2:542-553. [cited by applicant]
BARD Biopsy Systems, Biopsy Product Catalog (c. 2011), 36 pgs. [cited by applicant]
Best Approach for Prostate Cancer Detection: A Prospective Study on Transperineal Versus Transrectal Six-core Prostate Biopsy by P. Emiliozzi et al. Adult Urology. 961-966. 2003. (Year: 2003). [cited by applicant]
BK Medical, Endosonic Probe Type 1850 for BK Medical Ultrasound Scanners, Apr. 2010, 4 pgs. [cited by applicant]
Buchberger et al. Sonographically guided core needle biopsy of the breast: technique, accuracy, and indications. Radiology 2002; 42:25-32. [cited by applicant]
Chan et al. Computed tomography-guided transgluteal prostate biopsy using a coaxial needle system: technical note. Canadian Association of Radiologists (CARJ) Jun. 2003; vol. 54, No. 3, 181-182. [cited by applicant]
Coucher et al. Percutaneous coaxial needle biopsy using the spacer technique: a novel and easy modification to increase procedure safety. Clinical Radiology (2005) 60, 926-929. [cited by applicant]
EPO, Notice of Opposition to EP Patent 3827779, Opponent: Advance Medical Design Inc., dated Oct. 24, 2023, 9 pgs. [cited by applicant]
EPO, Notice of Opposition to EP Patent 3827779, Opponent: JA Kemp LLP, dated Oct. 25, 2023, 6 pgs. [cited by applicant]
Hopper et al. Percutaneous Biopsy of the Liver and Kidney by Using Coaxial Technique: Adequacy of the Specimen Obtained with Three Different Needles in vitro. AJR 1995; 164:221-224. [cited by applicant]
Hungr et al. A 3D Ultrasound Robotic Prostate Brachytherapy System with Prostate Motion Tracking. IEEE T-RO 11-0574 (2012), 16 pgs. [cited by applicant]
International Search Report and Written Opinion, PCT/US2023/030018, dated Jan. 31, 2024. [cited by applicant]
“Interventional Ultrasound” by H. Henrik et al.Ultrasound in Med. & Biol. vol. 22, No. 7, pp. 773-789, 1996 (Year: 1996). [cited by applicant]
Ja Kemp, Statement of Facts and Arguments in Support of Opposition EP 3827779, dated Oct. 25, 2023, 89 pgs. [cited by applicant]
Kilburn & Strode, Letter to EPO re EP Application No. 21153023.3, May 31, 2022, 7 pgs. [cited by applicant]
Moulton et al. Coaxial Percutaneous Biopsy Technique with Automated Biopsy Devices: Value in Improving Accuracy and Negative Predictive Value. Radiology 1993; 186:515-522. [cited by applicant]
Mozer et al. Robotic Image-Guided Needle Interventions of the Prostate. Reviews in Urology 2009; vol. 11 No. 1:7-15. [cited by applicant]
Order Granting Request for Reexamination re U.S. Pat. No. 11,446,056, U.S. Appl. No. 90/019,257, dated Oct. 26, 2023, 18 pgs. [cited by applicant]
Porter et al. Brachytherapy for Prostate Cancer. CA-A Cancer Journal for Clinicians, vol. 45, No. 3 May/Jun. 1995, pp. 165-178. [cited by applicant]
Ragde et al. Ultrasound-Guided Prostate Biopsy. Urology 1988; vol. XXXII, No. 6, 503-506. [cited by applicant]
Request for Ex Parte Reexamination of U.S. Pat. No. 10,064,681, dated Dec. 14, 2023, 76 pgs. [cited by applicant]
Request for Ex Parte Reexamination of U.S. Pat. No. 11,096,762, dated Dec. 27, 2023, 43 pgs. [cited by applicant]
Request for Ex Parte Reexamination of U.S. Pat. No. 11,246,677, dated Jan. 11, 2024, 64 pgs. [cited by applicant]
Request for Ex Parte Reexamination of U.S. Pat. No. 11,446,056, dated Sep. 22, 2023, 77 pgs. [cited by applicant]
USDC, District of Maryland, Corbin's Amended Responsive Claim Construction Brief, Case No. 1:22-cv-0789-SAG, filed Sep. 15, 2023, 59 pgs. [cited by applicant]
USDC, District of Maryland, Plaintiff Advance Medical Designs, Inc.'s Updated Opening Claim Construction Brief, Case No. 1:22-cv-00789-SAG, filed Jul. 31, 2023, 39 pgs. [cited by applicant]
Vereenigde Octrooiburea UX N.V., Letter to EPO in support of Opposition of EP 3827779 filed by Opponent Advance Medical Design, Inc., dated Oct. 24, 2023, 70 pgs. [cited by applicant]
Ahrar K., et al., Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP24—Biopsy Devices and Techniques, Chapter 1 Percutaneous Image-Guided Biopsy, Springer 2014, pp. 1-17. [cited by applicant]
Ahrar K., et al., “Dutch Patent Litigation Document Exhibit RP-7 Ultrasound-Guided Biopsy Chapter 4,” Percutaneous Image-Guided Biopsy, Springer, 2014, pp. 39-47. [cited by applicant]
Australian Examination Report for Australian Application No. 2015240520, mailed on Dec. 17, 2018, 3 Pages. [cited by applicant]
Australian Examination Report for Australian Application No. 2019203558, mailed on Feb. 26, 2020, 3 pages. [cited by applicant]
Batura D., et al., Prevalence of Antimicrobial Resistance in Intestinal Flora of Patients Undergoing Prostatic Biopsy: Implications for Prophylaxis and Treatment of Infections after Biopsy, BJU International, 2010, vol.… [cited by applicant]
BK Medical, “Biplane and Endfire Transducer User Guide Type 8818,” BK Ultrasound Model No. UA 1324, Jun. 2012, retrieved from the internet: URL: http://bkultrasound.com/support/bk/resources/user-manuals, 20 pages. [cited by applicant]
Bluvol., et al., Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP30-Freehand Versus Guided Breast Biopsy: Comparison of Accuracy, Needle Motion, and Biopsy Time in a Tissue Model, AJR:1… [cited by applicant]
Canadian Office Action for Canadian Application No. 2940211, mailed on Nov. 19, 2021, 6 pages. [cited by applicant]
Chang., et al., Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP31-Transperineal biopsy of the prostate-is this the future?, Nature Reviews, Urology, Dec. 2013, vol. 10, pp. 690-702. [cited by applicant]
Dundee., et al., “Dutch Patent Litigation Document Exhibit 24 Transperineal Prostate Biopsy: Template-Guided or Freehand?,” BJU International, 2014, vol. 681, No. 3, 3 pages. [cited by applicant]
Dutch Patent Litigation Document Deed Submitting Reactive Exhibits (English translation of Netherlands document), mailed on Nov. 16, 2021, 7 pages. [cited by applicant]
Dutch Patent Litigation Document Endosonic Probe User Guide Type 1850 BK Medical, Aug. 2006, 20 pages. [cited by applicant]
Dutch Patent Litigation Document Exhibit 19 Second Expert Report of Dr. Rick Popert MS FRCS (UROL), mailed on Nov. 15, 2021, 11 pages. [cited by applicant]
Dutch Patent Litigation Document Exhibit 21 Witness Statement of Dr. Matthew J. Allaway, mailed on Nov. 15, 2021, 9 pages. [cited by applicant]
Dutch Patent Litigation Document Expert Report of Dr. Rick Popert MS FRCS (UROL), mailed on Oct. 2021, 16 pages. [cited by applicant]
Dutch Patent Litigation Document Instrument on the Production of Counter-Productions, Nov. 23, 2021, 4 pages. [cited by applicant]
Dutch Patent Litigation Document Judgment Feb. 3, 2022, 20 pages. [cited by applicant]
Dutch Patent Litigation Document Statement from Jos J. Immerzeel MD, Nov. 22, 2021, 6 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense dated Nov. 2, 2021, Production GP15-Images of UA1232 Bk Medical, 20 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense (English translation of Netherlands document), mailed on Nov. 2, 2021, 68 pages. [cited by applicant]
Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production 16—Images of SureFire and UA1232 BK Medical, 6 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP18—Sasady WO99/034735, Jul. 15, 1999, 14 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP19—Transducer Type 8848 Product Data for BK Medical Ultrasound Systems, Oct. 2011, 3 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP20—Biplane Transducer Type 8808 User Guide BK Medical, Jun. 2012, 20 pages. [cited by applicant]
Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP21—Biplane and Endfire Transducer Type 8818 for BK Medical Ultrasound Scanners, Product Data, Apr. 2010, 4 pages. [cited by applicant]
Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP22—Endorectal Biplane Transducer Type 8808e for BK medical Ultrasound Scanners, Product Data, Aug. 2010, 4 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP23—Biplane and Endfire Transducer Type 8818 User Guide BK Medical, Jun. 2012, 20 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP32—Zur Früherkennung von Prostatakrebs, Gesundheitswesen, Oct. 2012, 2 pages. [cited by applicant]
Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP33—CareFusion Soft Tissue Biopsy Needles, 2011, 16 pages. [cited by applicant]
Dutch Patent Litigation Document Summons in Interlocutory Proceedings (English translation of Netherlands document), mailed on Oct. 21, 2021, 46 pages. [cited by applicant]
Dutch Patent Litigation Document Tru-Cut Soft Tissue Biopsy Needles, Instructions for Use, Aug. 7, 2019, 24 pages. [cited by applicant]
Dutch Patent Litigation Document Witness Statement from Assoc. Prof. Frantisek Zatura, M.D., Ph.D., Nov. 22, 2021, 11 pages. [cited by applicant]
Dutch Patent Litigation Document Witness Statement of Saheed Rashid, mailed on Oct. 15, 2021, 10 pages. [cited by applicant]
Emiliozzi., et al., “Dutch Patent Litigation Document, Exhibit MA-2 The Value of a Single Biopsy With 12 Transperineal Cores for Detecting Prostate Cancer in Patients with Elevated Prostate Specific Antigen,” Journal of… [cited by applicant]
European Examination Report for European Application No. 21153023.3, mailed on Mar. 24, 2022, 8 pages. [cited by applicant]
European Examination Report for European Application No. 15773805.5, mailed on Sep. 2, 2019, 5 Pages. [cited by applicant]
European Search Report for European Application No. 15773805.5, mailed on Oct. 13, 2017, 7 Pages. [cited by applicant]
Extended European Search Report for European Application No. 20155855.8, mailed on Apr. 23, 2020, 7 pages. [cited by applicant]
Extended European Search Report for European Application No. 21153023.3, mailed on May 3, 2021, 8 pages. [cited by applicant]
Ficarra., et al., Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP28—Needle Core Length is a Quality Indicator of Systematic Transperineal Prostate Biopsy, European Urology, 2006, vol. … [cited by applicant]
Ficarra V., et al., “Needle Core Length Is a Quality Indicator of Systematic Transperineal Prostate Biopsy,” 50 European Urology, 2006, vol. 266, 6 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/874,104, mailed on Jan. 17, 2020, 26 pages. [cited by applicant]
Galfano., et al., Dutch Patent Litigation Document, Statement of Defense Nov. 2, 2021, Production GP29—Prostate Biopsy: The Transperineal Approach, EAU-EBU Update Series 5, 2007, pp. 241-249. [cited by applicant]
Hatiboglu G., et al., “Application Technique: Placement of a Prostate-Rectum Spacer in Men Undergoing Prostate Radiation Therapy,” 110 BJU Int'l E647, May 10, 2012, 6 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2015/024339, mailed on Sep. 15, 2015, 13 Pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2021/025946, mailed on Aug. 23, 2021, 18 pages. [cited by applicant]
Liss MA., et al., “Prevalence and Significance of Fluoroquinolone Resistant [cited by applicant]
Loeb S., et al., “Complications after Prostate Biopsy: Data from SEER-Medicare,” Journal of Urology, 2011, vol. 186, No. 5, pp. 1830-1834. [cited by applicant]
Nam RK., et al., “Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy,” Journal of Urology, 2013, vol. 189, No. 1, retrieved from the internet: URL: http:… [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/677,286, mailed on Oct. 6, 2017, 6 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/874,104, mailed on Jul. 23, 2019, 17 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/115,180, mailed on Apr. 15, 2021, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/377,597, mailed on Jan. 22, 2020, 20 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/377,597, mailed on Sep. 26, 2019, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/377,754, mailed on Jan. 17, 2020, 21 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/377,754, mailed on Sep. 26, 2019, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/314,845, dated Jul. 22, 2021, 9 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/494,962, mailed on Feb. 3, 2022, 15 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/115,180, mailed on Jun. 7, 2021, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/377,597, mailed on Apr. 30, 2020, 29 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/377,754, mailed on May 7, 2020, 47 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/991,150, mailed on Oct. 26, 2022, 32 pages. [cited by applicant]
Novella., et al., Dutch Patent Litigation Document Statement of Defense Nov. 2, 2021, Production GP27—Pain Assessment after Original Transperineal Prostate Biopsy Using a Coaxial Needle, Urology, 2003, vol. 62, No. 4, p… [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 14/874,104, mailed on Apr. 16, 2020, 11 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 14/874,104, mailed on Oct. 21, 2019, 14 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 16/115,180, mailed on May 10, 2021, 9 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 16/377,597, mailed on Apr. 22, 2020, 14 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 16/377,597, mailed on Dec. 19, 2019, 13 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 16/377,754, mailed on Apr. 16, 2020, 14 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 16/377,754, mailed on Dec. 13, 2019, 11 pages. [cited by applicant]
Response to Non-Final Office Action for U.S. Appl. No. 17/314,845, mailed on Sep. 8, 2021, 8 pages. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 14/874,104, mailed on Jan. 22, 2019, 5 pages. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 14/874,104, mailed on Mar. 20, 2019, 10 pages. [cited by applicant]
Ristau., et al., “Dutch Patent Litigation Document Exhibit MA-1 Free-Hand Transperineal Prostate Biopsy Provides Acceptable Cancer Detection And Minimizes Risk Of Infection: Evolving Experience With A 10-Sector Template… [cited by applicant]
U.S. Patent Litigation Document, Answer, Affirmative Defenses, Counterclaims and Jury Demand, mailed on Apr. 15, 2022, 28 pages. [cited by applicant]
U.S. Patent Litigation Document Complaint for Declaratory Judgment of Patent Noninfringement, Invalidity, and Violation of Georgia Law, mailed on Oct. 22, 2021, 15 pages. [cited by applicant]
U.S. Patent Litigation Document, Corrected Answer, Affirmative Defenses, Counterclaims and Jury Demand, dated Apr. 18, 2022, 28 pages. [cited by applicant]
U.S. Patent Litigation Document, Exhibit A—Answer, Affirmative Defenses, Counterclaims and Jury Demand, dated Apr. 15, 2022, 13 pages. [cited by applicant]
U.S. Patent Litigation Document, Exhibit A—Second Amended Complaint for Declaratory Judgment of Patent Noninfringement and Invalidity, dated Jul. 20, 2022, 48 pages. [cited by applicant]
U.S. Patent Litigation Document, Exhibit B—Answer, Affirmative Defenses, Counterclaims and Jury Demand, dated Apr. 15, 2022, 17 pages. [cited by applicant]
U.S. Patent Litigation Document, Exhibit C—Answer, Affirmative Defenses, Counterclaims and Jury Demand, dated Apr. 15, 2022, 26 pages. [cited by applicant]
U.S. Patent Litigation Document Initial Disclosure of Infringement Contentions, dated Jun. 30, 2022, 235 Pages. [cited by applicant]
U.S. Patent Litigation Document Plaintiffs Initial Invalidity Contentions, dated Aug. 1, 2022, 103 pages. [cited by applicant]
Zangos S., et al., “MR-Guided Transgluteal Biopsies with an Open Low-Field System in Patients with Clinically Suspected Prostate Cancer: Technique and Preliminary Results,” 15 Euro Radiology 174, Sep. 4, 2004, 9 pages. [cited by applicant]
Eldred-Evans D., et al., “The Use of Transperineal Sector Biopsy as a First-Line Biopsy Strategy: A Multi-Institutional Analysis of Clinical Outcomes and Complications,” Urological Oncology, Exhibit 2015, Jun. 2016, 7 p… [cited by applicant]
EPO, Submission in Opposition Proceedings of EP3827779 Opponent: JA Kemp, Aug. 23, 2024, 100 pages. [cited by applicant]
Exhibit 2012 to Reply to Non-Final Office Action in Ex-Parte Re-Examination 90/019,257 dated Aug. 12, 2024, Expert Declaration of Dr. Rick Popert. [cited by applicant]
Exhibit 2013 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Aug. 12, 2024, CV of Dr. Rick Popert, MS (Lond). [cited by applicant]
Expert Declaration of Dr. Abhinav Sidana, dated Nov. 13, 2024, 42 pgs. [cited by applicant]
Expert Declaration of Dr. Abhinav Sidana, dated Dec. 9, 2024, 40 pgs. [cited by applicant]
Final Office Action in Re-Exam 90019257, dated Sep. 10, 2024, 34 pgs. [cited by applicant]
Gazelle G.S., et al., “Guided Percutaneous Biopsy of Intraabdominal Lesions,” American Journal of Roentgenology, Nov. 1, 1989, vol. 153, No. 5, pp. 929-935. [cited by applicant]
Hopper K.D., et al., “Multiple Fine-Needle Biopsies using a Coaxial Technique: Efficacy and a Comparison of Three Methods,” CardioVascular and Interventional Radiology, Sep. 1995, vol. 18, pp. 307-311. [cited by applicant]
Jones J.S., “Prostate Biopsy—Indications, Techniques and Complications,” Springer, 2008, 23 pages. [cited by applicant]
Kum F., et al., “Initial Outcomes of Local Anaesthetic Freehand Transperineal Prostate Biopsies in the Outpatient Setting,” Urological Oncology, Exhibit 2017, 2017, 26 pages. [cited by applicant]
MDL, “SemiCut,” MDL Catalog, Oct. 5, 2013, 1 page, Retrieved from the Internet: URL: https://pdf.medicalexpo.com/pdf/mdl/semicut/84369-100157.html. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/907,913, dated Dec. 2, 2024, 7 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/908,020, dated Nov. 27, 2024, 7 pgs. [cited by applicant]
Office Action in Ex Parte Re-Exam 90019257, dated Oct. 28, 2024, 20 pgs. [cited by applicant]
Office Action in Ex Parte Re-Exam 90019335, dated Sep. 10, 2024, 26 pgs. [cited by applicant]
Office Action in Ex Parte Re-Exam 90019354, dated Aug. 14, 2024, 15 pgs. [cited by applicant]
Office Action in Ex Parte Re-Exam 90019372, dated Sep. 19, 2024, 31 pgs. [cited by applicant]
Parker S.H., et al., “Image-Directed Percutaneous Biopsies with a Biopsy Gun,” Radiology, Jun. 1, 1989, vol. 171, No. 03, pp. 663-669. [cited by applicant]
Reply to Final Office Action for Ex-Parte Reexamination 90019257 , dated Oct. 3, 2024, 16 pgs. [cited by applicant]
Reply to Non-Final Office Action for Ex-Parte Reexamination 90019335, dated Dec. 10, 2024, 66 pgs. [cited by applicant]
Reply to Non-Final Office Action for Ex-Parte Reexamination 90019354 , dated Nov. 14, 24, 66 pgs. [cited by applicant]
Request for Ex Parte Reexamination of U.S. Pat. No. 11,547,436, dated Sep. 20, 2024, 74 pages. [cited by applicant]
Smith J.B., et al., “Transperineal Sector Prostate Biopsies: A Local Anesthetic Outpatient Technique,” Oncology, Exhibit 2016, 2014, 6 pages. [cited by applicant]
Stroman L., et al., “A Cross-section of UK Prostate Cancer Diagnostics During the Coronavirus Disease 2019 (Covid-19) Era—A Shifting Paradigm,” BJU International, Exhibit 2019, 2021, vol. 127, pp. 30-34. [cited by applicant]
Supplemental Response to Non-Final Office Action for Ex-Parte Reexamination 90/019,257, dated Aug. 12, 2024, 11 pages. [cited by applicant]
Tamhankar A.S., et al., “The Clinical and Financial Implications of a Decade of Prostate Biopsies in the NHS: Analysis of Hospital Episode Statistics Data 2008-2019,” BJU International, Exhibit 2018, 2020, 9 pages. [cited by applicant]
Vyas L., et al., “Indications, Results and Safety Profile of Transperineal Sector Biopsies (TPSB) of the Prostate: A Single Centre Experience of 634 Cases,” NHS Foundation Trust, 2014, Exhibit 2014, 22 pages. [cited by applicant]
Jun. 6, 2024_AU_Examination_Report_App_2023200954_6_pages. [cited by applicant]
Jun. 18, 2024 RE90019257 Examiner Interview Presentation, 22 pages. [cited by applicant]
Jun. 18, 2024 RE90019257 Interview Summary, 2 pages. [cited by applicant]
90019257 Reply to Non-Final Office Action for Ex-parte Reexamination, dated Jun. 27, 2024, 91 pgs. [cited by applicant]
EPO, Proprietor's Response to Notice of Opposition in EP3827779, dated May 10, 2024 110 pgs. [cited by applicant]
EX1016, Patent Owner's Amendment Infringement Contentions for the '681 Patent in [cited by applicant]
EX1018, Advance 'Medical's Updated Claim Construction Brief in Copending Litigation. [cited by applicant]
Exhibit 1004, Curriculum Vitae of Edward J. Yun. M.D. (4 pages). [cited by applicant]
Exhibit 1007, BK Medical, Prostate Biplane Transducer Type 8808e, User Guide (Jun. 2012) (16 pages). [cited by applicant]
Exhibit 1012, Japan Patent Publication No. 4-550531 B2 to Nakamura, entitled Puncture Adapter, dated Mar. 23, 2006 (36 pages). [cited by applicant]
Exhibit 1015, Declaration of Frantisek Zat'ura, M.D., Ph.D. from Related Proceeding in the Netherlands and certified English translation of the same (14 pages). [cited by applicant]
Exhibit 1016, Internet Archive Reports for BK Medical References (12 pages). [cited by applicant]
Exhibit 1017, Judgment issued Feb. 3, 2022 by the District Curt of the Hague, Case No. C/09/619229/KG ZA 21-974, [cited by applicant]
Exhibit 1017, Papers from Related Proceeding in the Netherlands with certified English translation (29 pages). [cited by applicant]
Exhibit 1018, Corbin Clinical Resources, LLC's Amended Proposed Claim Construction Statement and Advance Medical Designs, Inc.'s Supplemental Responsive Claim Construction Statement Pursuant to Local Rule 805(1)(b) (32 … [cited by applicant]
Exhibit 1019, Claim chart for U.S. Pat. No. 11,096,762 (70 pages). [cited by applicant]
Exhibit 1019, Patent Owner's Amended Infringement Contentions for the '677 Patent filed in [cited by applicant]
Exhibit 1019, Patent Owners Amendment Infringement Contentions for the 056 Patent filed in [cited by applicant]
Exhibit 2001 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Declaration of Dr. Abhinav Sidana, MBBS. [cited by applicant]
Exhibit 2002 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, CV of Dr. Abhinav Sidana, MBBS. [cited by applicant]
Exhibit 2004 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Schmeuesser, et al. (2022), Hundred years of transperineal prostate biopsy. [cited by applicant]
Exhibit 2005 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Grummet, et al. (2020), ‘TREXIT 2020’: why the time to abandon transrectal prostate biopsy starts now. [cited by applicant]
Exhibit 2006 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Expert Report of Dr. Rick Popert MS FRCS (UROL) prepared for the District Court of the Hague. [cited by applicant]
Exhibit 2007 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 datedJun. 27, 2024, Witness Statement of Dr. Matthew Allaway prepared for EPO Opposition to EP 827779B1. [cited by applicant]
Exhibit 2008 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Press Release, Men's Infection Risk Plunges under Prostate-Biopsy Method Adopted by Baylor St. Luke's Medical Group in… [cited by applicant]
Exhibit 2009 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Brotherhood of the Balloon, The PrecisionPoint Transperineal Biopsy, https://protonbob.com/precisionpoint-transperinea… [cited by applicant]
Exhibit 2010 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Hartford Healthcare, St. Vincent's Medical Center, This New Technology Makes Prostate Cancer Easier to Detect, https:/… [cited by applicant]
Exhibit 2011 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, YouTube Transcript, The PrecisionPoint Transperineal Access System ( http://perineologic.com), https://youtube/vV60sUQ… [cited by applicant]
Exhibit 2012 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Merit Medical Product Brochure for Tru-cut biopsy needles. [cited by applicant]
Exhibit 2013 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Jankowski M et al., Kidney biopsy in dogs and cats, Pak. Vet. J., 33(2): 133-138 (2013). [cited by applicant]
Exhibit 2014 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, BK Medical, Prostate Biplane Transducer 8808, User Guide (Mar. 2017) (“BK Medical 3”). [cited by applicant]
Exhibit 2015 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Winners Announced at the 19th Annual Medical Design Excellence Awards (MDEA) Award Ceremony, published Jun. 13, 2017. [cited by applicant]
Exhibit 2016 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, Meyer et al., Initial Experience Performing ln-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anes… [cited by applicant]
Exhibit 2017 to Reply to Non-Final Office Action in Ex-Parte Re-Exam 90/019,257 dated Jun. 27, 2024, BXTA, Transforming Local Anesthetic Prostate Biopsies with PrecisionPoint Transperineal Access SystemTM. [cited by applicant]
Extended European Search Report for European Application No. 21784653.4, mailed Apr. 8, 2024, 8 pages. [cited by applicant]
Non-Final Office Action, Re-Exam No. 90/019,257, dated Mar. 27, 2024, 33 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 17/214,323, dated Jul. 17, 2024, 8 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/390,094, dated May 24, 2024, 7 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/390,175, dated May 24, 2024, 7 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/390,212, dated Jun. 17, 2024, 8 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/390,250, dated Jun. 13, 2024, 8 pgs. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 18/533,466, dated Jul. 10, 2024, 31 pgs. [cited by applicant]
Ordering Granting Request for Ex Parte Reexamination of U.S. Pat. No. 11,096,762, mailed Feb. 6, 2024, 18 pages. [cited by applicant]
Ordering Granting Request for Ex Parte Reexamination of U.S. Pat. No. 10,064,681, mailed Feb. 6, 2024, 17 pages. [cited by applicant]
Ordering Granting Request for Ex Parte Reexamination of U.S. Pat. No. 11,246,677, mailed Feb. 6, 2024, 17 pages. [cited by applicant]
Petitioner's Request for Rehearing, Post Grant Review No. PGR2023-00041 (U.S. Pat. No. 11,547,436), [cited by applicant]
USDC, District of Maryland, Defendant Corbin Clinical Resources, LLC Second Amended Initial Disclosure of Infringement Contentions and Claim Charts for U.S. Pat. Nos. 11,446,056 and 11,547,436, Case No. 1:22-cv-00789-SA… [cited by applicant]
USPTO-PTAB, Decision Denying Petitioner's Request on Rehearing of Decision on Institution May 2, 2024, Post Grant Review No. PGR2023-00041 (U.S. Pat. No. 11,547,436), [cited by applicant]
Office Action in Ex Parte Re-Examination Application 90019354, dated Jan. 16, 2025, 39 pages. [cited by applicant]
Reply to Non-Final Office Action for Ex-Parte Reexamination in 90019257, dated Jan. 28, 2025, 37 pages. [cited by applicant]
Office Action in Ex Parte Re-Examination Application 90019372 dated Feb. 6, 2025, 44 pages. [cited by applicant]
Patent Owner's Petition to Vacate Order and Terminate Reexamination, Application 90019673, dated Feb. 10, 2025, 18 pages. [cited by applicant]
Office Action in Ex Parte Re-Examination Application 90019335 dated Feb. 12, 2025, 58 pages. [cited by applicant]